
Jadavpur University
Bachelor of Pharmacy (B.Pharm)
CompletedHi I am Joydeep Roy, an Indian origin pharmaceutical professional currently based in Nairobi, Kenya. Apart from Kenya, have managed India, Srilanka, Cambodia, UAE at various role and capacities.
SRI LANKACAMBODIAWorking in different markets has always widen my views & perpective
From the alleys of Kolkata to the boardrooms and roads of Nairobi, the thread that has guided my professional journey has been paying keen attention to the needs of healthcare markets.
After graduating from Jadavpur University with a bachelor’s degree in pharmaceutical technology, I started my career in pharmaceutical sales with Allergan India, a leader in ophthalmology. Over my sixteen-plus years in the industry, I have worked in product management, international marketing, training, sales-force effectiveness and new-product development. Currently based in Nairobi, Kenya, I work with Syner-Med Pharmaceuticals, looking after product management, training and digital initiatives.
Apart from India, I have also managed markets in the UAE, Sri Lanka and Cambodia in different roles and capacities.
A multidisciplinary academic journey that supports my work in pharmaceutical leadership and commercial decision-making.

Bachelor of Pharmacy (B.Pharm)
Completed
Post Graduate Diploma in Management (PGDM)
Completed
Post Graduate Certificate in Digital Marketing & Content Management
Completed
Executive Programme in Data Analytics
CompletedFrom field execution to business leadership, my roles connect customer understanding, brand strategy, capability building and digital growth.
Experience developed through association with pharmaceutical organizations across different roles, markets and stages of growth.








A B.Pharm education established the scientific base. Frontline sales and product roles in India then built a lasting respect for execution, customer insight and brand strategy.
Earlier business responsibility in these markets sharpened my approach: preserve strategic clarity, understand local context and never assume that one market’s answer automatically fits another.
Based in Nairobi, I currently manage the Kenya business—keeping strategy and decision-making connected to local healthcare priorities, customers and field teams.
My focus in Kenya is to strengthen brands, develop teams and use data, training and sales-force effectiveness to turn plans into consistent market action.

Honest conversations with pharmaceutical and healthcare leaders—exploring the people, decisions and turning points behind meaningful careers.
Real people. Real journeys. Real lessons from Pharmaceuticals.Coming SoonEasy-to-read thoughts on leadership, healthcare and business—based on what I have learned while working in Kenya, India, UAE, Sri Lanka and Cambodia.
Accountability matters, but people never forget how a leader treated them during their hardest moment.
Read the story →Sales teams, doctors and pharmacists often notice a change before it appears in a report.
Read the story →AI can make regulatory work faster and reduce effort—but every important answer still needs human validation.
Read the story →A concise, source-linked briefing on pharmaceutical research, public health and healthcare supply chains. Updated 29 October 2026.
Lilly reported that investigational retatrutide reduced HbA1c by 2.2 percentage points versus 1.8 with Ozempic at 80 weeks. Higher-dose retatrutide produced 20.9% weight loss versus 9.4%; detailed results are forthcoming, and the medicine remains unapproved.
Why it matters: Provides comparative evidence for diabetes treatment development, although complete safety data and regulatory assessment remain essential.
Read at Reuters →WHO published target profiles to guide injectable medicines for tuberculosis prevention and treatment. Goals include single-injection preventive treatment and disease treatment delivered through three or fewer dosing encounters over no more than four months; these are development targets, rather than approved regimens.
Why it matters: Gives developers and TB programmes shared benchmarks for efficacy, safety, affordability and simpler delivery, potentially reducing adherence barriers.
Read at WHO →The 2026 Lancet Countdown reports increasing health harms from heat, drought and other climate hazards. WHO’s account links heat to an estimated 710,000 deaths globally in 2023, while highlighting health benefits from cleaner energy and stronger early-warning systems.
Why it matters: Reinforces the need for climate-resilient healthcare facilities, heat preparedness and surveillance to protect vulnerable populations.
Read at WHO →Editorial summaries for general information only. Headlines link to the original sources; this section does not provide medical advice.
Join the mailing list for selected Healthcare Pulse updates, new journal entries and future Pharma Unscripted announcements. No spam—only relevant professional insights.
Based in Nairobi and currently managing the Kenya business, with earlier experience across India, UAE, Sri Lanka and Cambodia. Choose a channel below to connect.
“Every challenge is an invitation to think differently.”